United Parcel Service (UPS.US) announced its performance ahead of time and was included in Evercore's "Strategic Outperformance" list.
Evercore ISI has included it in the "Tactical Outperform" list. The organization has also raised the target price for the joint package to $147.
United Parcel Service (UPS.US) will announce its financial report on January 30th. Prior to this, Evercore ISI has included it in the "Tactical Outperform" list. The institution has also raised UPS's target price to $147.
Analyst Jonathan Chappell and his team believe that the stock may finally reverse some of the poor performance since mid-2023, and view the fourth quarter report and guidance update as a potential short-covering event.
Chappell added, "We note that data points have improved in our analysis of domestic and international revenue tracked, which could lead to an increase in earnings per share in the fourth quarter of 24, and more importantly, the risks to the 2025 earnings per share guidance may be seen as achievable (perhaps even exceeding expectations)."
Market expectations are for UPS to achieve revenue of $25.4 billion in the fourth quarter, with earnings per share of $2.53. It is worth noting that the company has exceeded earnings expectations in five out of the last six quarters, but has fallen short of revenue expectations in eight out of the last nine quarters. Options trading implies a 4.5% volatility in the stock price after the financial report is released next week.
Related Articles

US Stock Market Move | Mexican airline (AERO.US) landed on the US stock market and opened with a rise of more than 2.8%.

US Stock Market Move | Biopharmaceutical company Evommune (EVMN.US) debuts on the US stock market with a stock price surge of over 15%.

US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.
US Stock Market Move | Mexican airline (AERO.US) landed on the US stock market and opened with a rise of more than 2.8%.

US Stock Market Move | Biopharmaceutical company Evommune (EVMN.US) debuts on the US stock market with a stock price surge of over 15%.

US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


